Wave Life Sciences (WVE) Net Cash Flow Growth (1y) (2015 - 2026)
Wave Life Sciences (WVE) Net Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Wave Life Sciences | 1.19 Bn | 649.41 Mn | - | 2.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.68% |
| Dec 31, 2025 | 4,737.50% |
| Sep 30, 2025 | -107.79% |
| Jun 30, 2025 | -28.88% |
| Mar 31, 2025 | -205.34% |
| Dec 31, 2024 | -114.50% |
| Sep 30, 2024 | 575.63% |
| Jun 30, 2024 | 24.28% |
| Mar 31, 2024 | -116.10% |
| Dec 31, 2023 | 806.46% |
| Sep 30, 2023 | -26.23% |
| Jun 30, 2023 | -157.60% |
| Mar 31, 2023 | 235.29% |
| Dec 31, 2022 | -131.95% |
| Sep 30, 2022 | -31.09% |
| Jun 30, 2022 | 1,411.86% |
| Mar 31, 2022 | -147.66% |
| Dec 31, 2021 | 183.70% |
| Sep 30, 2021 | -116.30% |
| Jun 30, 2021 | 82.55% |